#WhatIs #Pharmacology #Immunology #Biotechnology #MolecularBiology #Biomanufacturing #sflorg
https://www.sflorg.com/2026/04/wi04212601.html
Axplora Expands Manufacturing Facilities at Its Italian Farmabios Site
Axplora, which develops and manufactures highly potent active pharmaceutical in…
#dining #cooking #diet #food #Italianingredient #axplora #biomanufacturing #biopharmaceuticals #bioprocessing #drugdevelopment(researchanddevelopment) #IndustryNews #ingredient #Italia #Italian #italiano #italy #news #QualityControl
https://www.diningandcooking.com/2586519/axplora-expands-manufacturing-facilities-at-its-italian-farmabios-site-2/
PHY906 is a case study in why pharmaceutical-grade plant medicine demands more than good genetics and QC after the fact. When therapeutic effect depends on compound ratios across multiple species, environmental control becomes the upstream regulator.
This is where CEA shifts from “alternative farming” to critical infrastructure for medicine.
#ControlledEnvironmentAgriculture #MedicinalPlants #PlantScience #BioManufacturing
NVIDIA Healthcare (@NVIDIAHealth)
@multiplylabs가 무균 환경을 전제로 한 엔드투엔드 로보틱스 시스템으로 유전자변형 세포치료제의 대규모 제조를 지원한다고 소개했습니다. 이 솔루션은 정밀도 향상과 오염 감소를 통해 셀·유전자 치료제의 확장 가능하고 자동화된 바이오제조를 목표로 합니다.
💡 What do chips and drugs have in common? Both rely on ultra‑clean environments to prevent contamination and ensure quality. 🧬 @multiplylabs delivers end‑to‑end robotic systems that manufacture gene‑modified cell therapies at scale - boosting precision, reducing contamination,
#Newswire: Cellular Agriculture Australia announces a new report authored in collaboration with Agrifood Innovation Institute, Australian Strategic Policy Institute, and the ANU National Security College. The white paper highlights the role of food security in safeguarding national security and positions food biotechnologies and biomanufacturing as critical to this objective.
#cellculture #microbial #ingredients #protein #foodtech #biotech #innovation #biomanufacturing
A new report calls on the Australian Government to capitalise on an opportunity to leverage Australia’s existing competitive advantage and build sovereign capability in food biotechnology and biomanufacturing.
Samsung Biologics Co. secures a $1.3 billion CMO contract with a US pharmaceutical firm, pushing its 2025 order intake past 5 trillion won and reinforcing its global leadership in biomanufacturing capacity.